Glycopyrrolate
- Product NDC
- 0722-7097
- 11-digit product format
- 007227097
- Labeler code
- 0722
- Product ID
- 0722-7097_9e901d90-08ba-4143-8e0c-1bd15b72e0de
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glycopyrrolate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Nexgen Pharma, Inc.
- Application
- ANDA091522
- Marketing category
- ANDA
- Marketing start
- 2012-03-12
- Marketing end
- 0000-00-00
- Substance
- GLYCOPYRROLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Anticholinergic [EPC],Cholinergic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 0722-7097 | I | Inactivated by FDA | 2026-10-02 | ||
| excluded package | package | 0722-7097 | 0722-7097-01 | I | Inactivated by FDA | 2026-10-02 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 0722-7097-01 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 0722-7097-01 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 0722-7097-01 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 0722-7097-01 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 0722-7097-01 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 0722-7097-01 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 0722-7097-01 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 0722-7097-01 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 0722-7097-01 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 0722-7097-01 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 0722-7097-01 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 0722-7097-01 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 0722-7097-01 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 0722-7097-01 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 0722-7097-01 | 1332a3947898… | d4bfe170f9cd… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 0722-7097-01 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 0722-7097-01 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 0722-7097-01 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 0722-7097-01 | 8dfbde2a14a4… | c9ff85d89658… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091522-001 | GLYCOPYRROLATE | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | RS | 2012-03-12 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | RS | 2012-03-12 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | RS | 2012-03-12 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | RS | 2012-03-12 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | RS | 2012-03-12 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | RS | 2012-03-12 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | RS | 2012-03-12 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | RS | 2012-03-12 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | RS | 2012-03-12 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | RS | 2012-03-12 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | RS | 2012-03-12 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | RS | 2012-03-12 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | RS | 2012-03-12 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | RS | 2012-03-12 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A091522-001 | GLYCOPYRROLATE | 1.5MG | TABLET / ORAL | 2012-03-12 | f41ea6bd6efb… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 138c3de2-4b03-4255-92b5-f022482d81bc | Product name | 4 | 20260113 |
| 4dc252b1-bb5f-8bb6-4fa8-f3a45efd810e | Product name | 5 | 20250304 |
| f58f10d3-5fa9-4c2e-9a6e-77029e9ed80b | Product name | 1 | 20231002 |
| 76dcac30-469f-4f92-9c55-70950d209446 | Product name | 1 | 20230809 |
| 132196a6-5117-4b6e-a9dd-27f2793580c6 | Product name | 1 | 20230112 |
| ac1f888b-a1db-4d2e-abbc-973f21c2ce1b | Product name | 1 | 20220720 |
| d84dd569-7bf0-1410-25eb-017ef37dd406 | Product name | 9 | 20210902 |
| 7d8c8d5a-f174-4e6b-97b1-6fd615c5df9a | Product name | 1 | 20210204 |
| 58b12de9-b891-41c7-9be6-ff47de5ec28b | Product name | 1 | 20180828 |
| 9aff7b10-8e47-4b10-9a92-803440a37ce2 | Product name | 1 | 20180206 |
| ce066c73-ca6f-49fc-83d4-d3cf6728e8a1 | Product name | 1 | 20160616 |
| fb29b8a9-c2d0-42bb-aea8-9bc2a87db75a | Product name | 1 | 20151113 |
| ab7ba50c-5a47-47e6-8dd6-fa32a52559f6 | Product name | 1 | 20151109 |
| 29ae08d1-069f-9822-4820-152d5dc67797 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0722-7097-01 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3c90-a910-e053-dadaa90a0b85 | GLYCOPYRROLATE TABLETS, USP, 1.5 MG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0722-7097-01 | Glycopyrrolate | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 3 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GLYCOPYRROLATE | ACTIVE INGREDIENT | V92SO9WP2I | GLYCOPYRROLATE TABLET [NEXGEN PHARMA, INC.] | 1 | |
| GLYCOPYRROLATE | ACTIVE MOIETY | V92SO9WP2I | GLYCOPYRROLATE TABLET [NEXGEN PHARMA, INC.] | 1 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | GLYCOPYRROLATE TABLET [NEXGEN PHARMA, INC.] | 1 | |
| CALCIUM PYROPHOSPHATE | INACTIVE INGREDIENT | X69NU20D19 | GLYCOPYRROLATE TABLET [NEXGEN PHARMA, INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | GLYCOPYRROLATE TABLET [NEXGEN PHARMA, INC.] | 1 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | GLYCOPYRROLATE TABLET [NEXGEN PHARMA, INC.] | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | GLYCOPYRROLATE TABLET [NEXGEN PHARMA, INC.] | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycate | GLYCOPYRROLATE | Intra-Sana Laboratories | 830ba1be-bef3-417c-a915-964cc6005b92 | 2026-01-13 | Warnings, Adverse reactions | 091522 ANDA091522 |
| GLYCOPYRROLATE | GLYCOPYRROLATE | FH2 Pharma LLC | 18ca98ed-522d-470f-bb22-908bbd7d489a | 2023-12-31 | Warnings, Adverse reactions | 091522 ANDA091522 |
| Glycopyrrolate | GLYCOPYRROLATE | LGM PHARMA SOLUTIONS, LLC | 392a969d-1e14-4ad8-835c-a47be4983067 | 2023-04-27 | Warnings, Adverse reactions | 091522 ANDA091522 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1247658 | glycopyrrolate 1.5 MG Oral Tablet | PSN | 06bb6f89-4694-4aaa-8bff-f7f3c81d3add | 3 |
| 1247658 | glycopyrrolate 1.5 MG Oral Tablet | SCD | 06bb6f89-4694-4aaa-8bff-f7f3c81d3add | 3 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 0722-7097-01 | 00722709701 | 100 in 1 BOTTLE, PLASTIC | Historical |